2020

Article in NZZ am Sonntag giving a comprehensive overview of the problem of combatting multiresistant bacteria including activities within the NCCR Antiresist: "The world needs new antbiotics".

Collaboration between spinoff InSphero AG and BEL or BSSE served as case study at workshop on academic industry collaborations in Basel Area.

BEL paper in Nature Communications on high-density microelectrode arrays with dual-mode capabilities covered in Nature Methods as "Research Highlight".

Movie on innovation in fighting resistance against antibiotics within the NCCR "Antiresist" including BEL contribution presented at Swiss Innovation Forum 2020.  

Increasing drug-drug interactions in patients, treated with multiple medicines, require new methods to detect such complications. We developed a microfluidic in-vitro system that enables qualitative and quantitative assessments.

New CMOS microelectrode system, featuring two simultaneously operated readout modes - full frame and switch matrix - for studying electrical activity and interaction of thousands of neuronal cells.

BEL contributed large-scale electrophysiological measurements and corresponding data analysis to characterization of light-sensitive human retinal organoids, developed by Roska group at IOB. Results have been published in journal Cell.

BEL Contribution to "Views" in Journal Cell Systems on how microfluidic and microfabrication approaches can contribute to enhance physiological relevance of experiments in biology and biomedicine.  

BEL spinoff, MaxWell Biosystems AG, founded 2016, reached rank 59 in the Swiss Top 100 Startup Competition 2020. MaxWell was listed as Biotech company.

License agreement for Akura™ Flow organ-on-a-chip platform concluded between ETH Zurich, Bio Engineering Laboratory, and InSphero AG.

Outstanding Paper Award of Microsystems & Nanoengineering to P. Misun and co-authors for paper"Multi-analyte Biosensor Interface for Real-time Monitoring of 3D Microtissue Spheroids in Hanging-drop Networks".  

Article on new microfluidic testing platform that will help diabetes researchers to find new drugs and to get deeper insights into underlying biological mechanisms in ETH Industry News.

As current drug screening methods are hampered by low throughput and potential subjectivity in parasite-phenotype evaluation, electrical impedance platform and method to screen for drugs against parasites, such as Schistosoma mansoni, has been developed.

New paper in Science Advances describing massively parallel microwire arrays for in-vivo neural recording includes CMOS high-density microelectrode-array chips developed at BEL.

New ETH postdoctoral fellow in our group, working on computational modeling of neuronal networks, Alessio Buccino, was interviewed for the News page of the Department BSSE.